Literature DB >> 31829454

Bridging the knowledge gap on mycoses in Africa: Setting up a Pan-African Mycology Working Group.

Rita O Oladele1, Iorhen E Akase2, Ahmed H Fahal3, Nelesh P Govender4, Martin Hoenigl5,6, Jean Pierre Gangneux7, Tom M Chiller8, David W Denning9,10, Oliver A Cornely11,12,13, Arunaloke Chakrabarti14.   

Abstract

Most African countries have poorly funded and overburdened health systems. Additionally, a high prevalence of HIV in Sub-Saharan Africa contributes to a high burden of opportunistic fungal infections. Data generated by GAFFI from 15 of 57 African countries revealed that an estimated 47 million Africans suffer from fungal diseases, of whom an estimated 1.7 million suffer from a serious fungal infection annually. Almost all African countries lack a surveillance system for fungal infections with the exception of South Africa. South Africa is also the only African country with a national mycology reference laboratory. Across the continent, there is a pervasive picture of inadequate/poor diagnostic capacity, low level of awareness among healthcare workers and policymakers and unavailability and non-accessibility to essential antifungal medications. Recent outreach efforts by the International Society for Human and Animal Mycology (ISHAM) and the European Confederation of Medical Mycology (ECMM) have aimed to increase involvement of African countries and experts in global initiatives such as "One World One Guideline" and also the ECMM Academy. Recently, under the auspices of ISHAM, the African sub-region created a network of mycology experts whose goal is to organise and engage African leaders in the field of medical mycology. The aim of this ISHAM Working Group was to facilitate interaction and synergy among regional leaders in order to develop educational programmes for capacity building to aid in the diagnosis and care of patients with fungal infections in Africa. The working group will also encourage country initiatives to develop clinical guidelines, to support surveys and to support the establishment of reference mycology laboratories.
© 2019 Blackwell Verlag GmbH.

Entities:  

Keywords:  AIDS; HIV infection; antifungal agents; epidemiology; mycetoma

Year:  2019        PMID: 31829454     DOI: 10.1111/myc.13044

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  6 in total

1.  Detection and Control of Fungal Outbreaks.

Authors:  Diego H Caceres; Ratna Mohd Tap; Ana Alastruey-Izquierdo; Ferry Hagen
Journal:  Mycopathologia       Date:  2020-10-10       Impact factor: 2.574

2.  Triazole susceptibility of Aspergillus species: environmental survey in Lagos, Nigeria and review of the rest of Africa.

Authors:  Cynthia Abosede Campbell; Iriagbonse Iyabo Osaigbovo; Rita Okeoghene Oladele
Journal:  Ther Adv Infect Dis       Date:  2021-09-12

Review 3.  Fungal CNS Infections in Africa: The Neuroimmunology of Cryptococcal Meningitis.

Authors:  Sally H Mohamed; Tinashe K Nyazika; Kenneth Ssebambulidde; Michail S Lionakis; David B Meya; Rebecca A Drummond
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

4.  Endemic mycoses in South Africa, 2010-2020: A decade-long description of laboratory-diagnosed cases and prospects for the future.

Authors:  Rutendo E Mapengo; Tsidiso G Maphanga; Wayne Grayson; Nelesh P Govender
Journal:  PLoS Negl Trop Dis       Date:  2022-09-28

5.  Improving awareness, diagnosis and management of invasive fungal infections in Ghana: establishment of the Ghana Medical Mycology Society.

Authors:  Bright K Ocansey; Edmund A Dadzie; Stephen K Eduful; Martin Agyei; Mary-Magdalene Osei; Peter Puplampu; Isabella Asamoah; Rita O Oladele; Iriagbonse I Osaigbovo; Jane S Afriyie-Mensah; Japheth A Opintan; Samuel Essien-Baidoo; Arunaloke Chakrabarti; Martin Hoenigl; David W Denning; Malcolm D Richardson
Journal:  Med Mycol       Date:  2022-09-29       Impact factor: 3.747

6.  Determining the burden of fungal infections in Zimbabwe.

Authors:  Lorraine T Pfavayi; David W Denning; Stephen Baker; Elopy N Sibanda; Francisca Mutapi
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.